Call Pharmacy +91 90310 13315

Rapilif-D 8 New Capsule

Silodosin (8mg) + Dutasteride (0.5mg)

₹387.90 ₹456.3515% Off

Out of Stock


Product Code: 490710
Availability: Out of Stock
Manufacturer: Ipca Laboratories Ltd
Constituents

Silodosin (8mg) + Dutasteride (0.5mg)

Usage of Rapilif-D 8 New Capsule

Rapilif-D 8 New Capsule is used in the treatment of benign prostatic hyperplasia.

Possible Side-effects

Common
  • Ejaculation disorder
  • Retrograde ejaculation
  • Impotence
  • Breast pain

Unit

1 Strip of 10 Capsules

Manufacturer

Ipca Laboratories Ltd

Disclaimer

Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.

How to use Rapilif-D 8 New Capsule

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rapilif-D 8 New Capsule is to be taken with food.
This will help to avoid the side effects.

How Medicine Works

Rapilif-D 8 New Capsule is a combination of two medicines: Silodosin and Dutasteride, which relieves the symptoms of benign prostatic hyperplasia. Silodosin is an alpha-blocker. It works by relaxing the muscle around the bladder exit and prostate gland so

Related Warnings

Taking Silodosin with alcohol may have additive effects in lowering your blood pressure. You may experience a headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

Rapilif-D 8 New Capsule is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.

No information is available on the use of Rapilif-D 8 New Capsule during lactation. Please consult your doctor.

Dizziness or weakness due to low blood pressure may occur in some patients while on Rapilif-D 8 New Capsule. If you are affected in this way, your ability to drive may be impaired.

Rapilif-D 8 New Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rapilif-D 8 New Capsule may not be needed in these patients. Please consult your doctor.

Rapilif-D 8 New Capsule should be used with caution in patients with liver disease. Dose adjustment of Rapilif-D 8 New Capsule may be needed. Please consult your doctor.
Use of Rapilif-D 8 New Capsule is not recommended in patients with severe liver d

Expert Advice

  • You have be

Frequently Asked Questions (FAQs)

Q. What is benign prostate hyperplasia (BPH)?

Benign prostatic hyperplasia (BPH) is a common condition in older men. It is also known as prostate g

Similar Products

In-Stock
Silorap D 8mg/0.5mg Tablet

Silorap D 8mg/0.5mg Tablet

₹363356.00
In-Stock
Maxvoid Plus 8 CP Tablet

Maxvoid Plus 8 CP Tablet

₹11901012.00
In-Stock
Maxvoid 8 CP Tablet

Maxvoid 8 CP Tablet

₹838712.00
Out of Stock
Alphacept 8 Capsule

Alphacept 8 Capsule

₹242205.49

Featured Products

In-Stock
A-Z Tablet

A-Z Tablet

₹110107.80
Out of Stock
Gastid Syrup

Gastid Syrup

₹7775.46
In-Stock
Calcit SG Capsule

Calcit SG Capsule

₹124121.13
Keywords: Rapilif-D 8/0.5 Tablet, Rapilif-D 8/0.5 Tablet price, Rapilif-D 8/0.5 Tablet alternatives, Silodosin+Dutasteride